James Lightwood, PhD

TitleAssociate Professor
SchoolUCSF School of Pharmacy
DepartmentClinical Pharmacy
Address3333 Calif. St,Laurel Heights
San Francisco CA 94118
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yao T, Max W, Sung HY, Glantz SA, Goldberg RL, Wang JB, Wang Y, Lightwood J, Cataldo J. Relationship between spending on electronic cigarettes, 30-day use, and disease symptoms among current adult cigarette smokers in the U.S. PLoS One. 2017; 12(11):e0187399. PMID: 29112988.
      View in: PubMed
    2. Wang Y, Sung HY, Yao T, Lightwood J, Max W. Infrequent and Frequent Nondaily Smokers and Daily Smokers: Their Characteristics and Other Tobacco Use Patterns. Nicotine Tob Res. 2017 Feb 10. PMID: 28186549.
      View in: PubMed
    3. Wang Y, Sung HY, Yao T, Lightwood J, Max W. Factors associated with short-term transitions of non-daily smokers: socio-demographic characteristics and other tobacco product use. Addiction. 2017 May; 112(5):864-872. PMID: 27886652.
      View in: PubMed
    4. Lightwood J, Glantz SA. Smoking Behavior and Healthcare Expenditure in the United States, 1992-2009: Panel Data Estimates. PLoS Med. 2016 May; 13(5):e1002020. PMID: 27163933; PMCID: PMC4862673.
    5. Yao T, Sung HY, Wang Y, Lightwood J, Max W. Sociodemographic Differences Among U.S. Children and Adults Exposed to Secondhand Smoke at Home: National Health Interview Surveys 2000 and 2010. Public Health Rep. 2016 Mar-Apr; 131(2):357-66. PMID: 26957671; PMCID: PMC4765985 [Available on 03/01/17].
    6. Sung HY, Wang Y, Yao T, Lightwood J, Max W. Polytobacco Use of Cigarettes, Cigars, Chewing Tobacco, and Snuff Among US Adults. Nicotine Tob Res. 2016 May; 18(5):817-26. PMID: 26136525.
      View in: PubMed
    7. Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K. Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model. PLoS One. 2013; 8(12):e81723. PMID: 24349119; PMCID: PMC3859539.
    8. Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients. J Manag Care Pharm. 2013 Sep; 19(7):534-41. PMID: 23964614.
      View in: PubMed
    9. Lightwood J, Glantz SA. The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989-2008. PLoS One. 2013; 8(2):e47145. PMID: 23418411; PMCID: PMC3572143.
    10. Max W, Sung HY, Lightwood J. The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016. Tob Control. 2013 May; 22(e1):e10-5. PMID: 22253003.
      View in: PubMed
    11. Cheng KW, Glantz SA, Lightwood JM. Association between smokefree laws and voluntary smokefree-home rules. Am J Prev Med. 2011 Dec; 41(6):566-72. PMID: 22099232; PMCID: PMC3222862.
    12. Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA. Evaluation of value-based insurance design with a large retail employer. Am J Manag Care. 2011 Oct; 17(10):682-90. PMID: 22106461.
      View in: PubMed
    13. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011 Sep; 124(9):827-33.e5. PMID: 21722862; PMCID: PMC3159777.
    14. Lightwood J, Glantz S. Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Soc Sci Med. 2011 Jan; 72(2):166-72. PMID: 21168248; PMCID: PMC3603372.
    15. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18; 362(7):590-9. PMID: 20089957; PMCID: PMC3066566.
    16. Wang LM, Wong M, Lightwood JM, Cheng CM. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Ann Pharmacother. 2010 Jan; 44(1):28-34. PMID: 20040698.
      View in: PubMed
    17. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health. 2009 Dec; 99(12):2230-7. PMID: 19833999; PMCID: PMC2775763.
    18. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009 Oct 06; 120(14):1373-9. PMID: 19770392; PMCID: PMC2967202.
    19. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009 Feb 17; 150(4):243-54. PMID: 19221376.
      View in: PubMed
    20. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med. 2009 Jan; 36(1):13-20. PMID: 19095162; PMCID: PMC3940697.
    21. Lightwood JM, Dinno A, Glantz SA. Effect of the California tobacco control program on personal health care expenditures. PLoS Med. 2008 Aug 26; 5(8):e178. PMID: 18752344; PMCID: PMC2522256.
    22. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007 Dec 06; 357(23):2371-9. PMID: 18057339.
      View in: PubMed
    23. Soller RW, Lightwood JM. Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling. J Am Pharm Assoc (2003). 2007 Jul-Aug; 47(4):484-90. PMID: 17616494.
      View in: PubMed
    24. Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res. 2005 Oct-Dec; 32(4):381-92. PMID: 16215448.
      View in: PubMed
    25. Lightwood J. The economics of smoking and cardiovascular disease. Prog Cardiovasc Dis. 2003 Jul-Aug; 46(1):39-78. PMID: 12920700.
      View in: PubMed
    26. Lightwood J, Fleischmann KE, Glantz SA. Smoking cessation in heart failure: it is never too late. J Am Coll Cardiol. 2001 May; 37(6):1683-4. PMID: 11345384.
      View in: PubMed
    27. Wilson LS, Lightwood J. Model of estimated rates of colorectal cancer from polyp growth by year of surveillance. J Med Screen. 2001; 8(4):187-96. PMID: 11743035.
      View in: PubMed
    28. Lightwood JM, Phibbs CS, Glantz SA. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics. 1999 Dec; 104(6):1312-20. PMID: 10585982.
      View in: PubMed
    29. Wilson LS, Lightwood JM. Pancreatic cancer: total costs and utilization of health services. J Surg Oncol. 1999 Jul; 71(3):171-81. PMID: 10404134.
      View in: PubMed
    30. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation. 1997 Aug 19; 96(4):1089-96. PMID: 9286934.
      View in: PubMed
    31. Glantz SA, Fox BJ, Lightwood JM. Tobacco litigation. Issues for public health and public policy. JAMA. 1997 Mar 05; 277(9):751-3. PMID: 9042849.
      View in: PubMed
    James's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP